Avery Dennison Announces Second Quarter 2021 Results
Highlights:
-
2Q21 Reported EPS of
$2.19 , up 131%-
Adjusted EPS (non-GAAP) of
$2.25 , up 77%
-
Adjusted EPS (non-GAAP) of
-
2Q21 Net sales increased 37.5% to
$2.10 billion - Sales growth ex. currency (non-GAAP) of 29.2%
- Organic sales growth (non-GAAP) of 28.1%
-
Raised FY 2021 EPS guidance ranges
-
Reported EPS range now
$8.50 to$8.80 (previously$8.25 to$8.65 ) -
Adjusted EPS range now
$8.65 to$8.95 (previously$8.40 to$8.80 )
-
Reported EPS range now
-
Announced agreement to acquire
Vestcom for$1.45 billion
“We delivered another strong quarter, ahead of expectations, raised our outlook for the second half, and announced an agreement to acquire
“Our strong performance comes at a time when supply chains remain tight, inflation persists and the global health crisis continues. The current environment reinforces our determination to remain vigilant in ensuring the health and well-being of our employees, delivering for our customers, supporting our communities, and creating value for our shareholders.
“Vestcom, a high growth, high margin business, provides retail shelf-edge pricing and branding labeling solutions. The acquisition will further expand our position in high value categories while adding channel access and data management capabilities to RBIS that have the potential to further advance our Intelligent Labels strategy,” added Butier.
“Once again, I want to thank our entire team for their ongoing efforts to keep one another safe while continuing to deliver for all our stakeholders during this challenging period.”
Operational/Market Update
Uncertainty surrounding the global health crisis remains elevated as many parts of the world are experiencing a surge in COVID-19 cases, with the greatest impact to the company being in
The company continues to actively manage through a dynamic supply and demand environment. Demand across the majority of businesses and regions remains very strong, while raw materials, freight and labor availability continue to be constrained. The company is leveraging its global scale and working closely with customers and suppliers to minimize disruptions. Inflation remains persistent and pricing and material re-engineering actions are being implemented to offset higher costs.
Second Quarter 2021 Results by Segment
Label and Graphic Materials
-
Reported sales increased 25% to
$1.4 billion . Compared to prior year, sales were up 17% ex. currency (up 11% vs. 2019) and up 16% on an organic basis (up 11% vs. 2019).- Label and Packaging Materials sales were up approximately 12% from prior year on an organic basis, with strong growth in both the high value product categories and the base business.
- Sales increased by approximately 49% organically in the combined Graphics and Reflective Solutions businesses.
-
On an organic basis, sales were up high-single digits in
North America , up mid-teens inWestern Europe , and up approximately 20% in emerging markets.
- Reported operating margin increased 410 basis points to 16.6%. Adjusted operating margin decreased 30 basis points to 14.5% driven by the net impact of pricing and raw material costs and higher employee-related costs, partially offset by higher volume/mix.
Retail Branding and Information Solutions
-
Reported sales increased 80% to
$529 million . Compared to prior year, sales were up 73% ex. currency (up 25% vs. 2019) and up 72% on an organic basis (up 14% vs. 2019), reflecting strong growth in both the high value categories and the base business.- Intelligent Labels was up approximately 65% organically.
- Reported operating margin increased 1160 basis points to 8.0%. Adjusted operating margin increased 1240 basis points to 13.1% as the benefits from higher volume and productivity more than offset the headwind from prior year temporary cost reduction actions, higher employee-related costs and growth investments.
Industrial and Healthcare Materials
-
Reported sales increased 49% to
$197 million . Compared to prior year, sales were up 39% ex. currency (up 11% vs. 2019) and up 33% on an organic basis (up 6% vs. 2019), reflecting an approximately 60% increase in industrial categories and a high-single digit decline in healthcare categories.
- Reported operating margin increased 580 basis points to 11.5%. Adjusted operating margin increased 490 basis points to 11.7% as the benefit from higher volume/mix more than offset the headwind from prior year temporary cost reduction actions and higher employee-related costs.
Other
Balance Sheet, Liquidity, and Capital Deployment
The company’s balance sheet remains strong, with ample capacity. Net debt to adjusted EBITDA (non-GAAP) was 1.3 at the end of the second quarter, below its long-term target.
In the first half, the company returned
The company repurchased 0.2 million shares in the second quarter at an aggregate cost of
In
The company recorded a contingent liability during the quarter in the amount of
The company announced today that it has signed an agreement to acquire
Income Taxes
The company’s second quarter effective tax rate was 27.6%. The adjusted (non-GAAP) tax rate for the quarter was 25.6%, while the company’s current expectation for its full year adjusted tax rate is 25.3%.
Cost Reduction Actions
In the second quarter, the company realized approximately
Outlook
In its supplemental presentation materials, “Second Quarter 2021 Financial Review and Analysis,” the company provides a list of factors that it believes will contribute to its 2021 financial results. Based on the factors listed and other assumptions, the company has raised its guidance range for 2021 reported earnings per share from
Note: 2021 estimates do not include the impact of
For more details on the company’s results, see the summary tables accompanying this news release, as well as the supplemental presentation materials, “Second Quarter 2021 Financial Review and Analysis,” posted on the company’s website at www.investors.averydennison.com, and furnished to the
Throughout this release and the supplemental presentation materials, amounts on a per share basis reflect fully diluted shares outstanding.
About Avery Dennison
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995
Certain statements contained in this document are “forward-looking statements” intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties. Forward-looking statements also include those related to the acquisition of
We believe that the most significant risk factors that could affect our financial performance in the near-term include: (i) the impacts to underlying demand for our products and/or foreign currency fluctuations from global economic conditions, political uncertainty, changes in environmental standards and governmental regulations, including as a result of the coronavirus/COVID-19 pandemic; (ii) competitors’ actions, including pricing, expansion in key markets, and product offerings; (iii) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; and (iv) the execution and integration of acquisitions, including the pending acquisition of
Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but are not limited to, risks and uncertainties relating to the following:
- COVID-19
-
The
Vestcom acquisition – our ability to complete the acquisition on the proposed terms or anticipated timeline, including risks and uncertainties related to securing the necessary regulatory approvals, financing and satisfaction of other closing conditions to complete the acquisition; the occurrence of any event, change or other circumstance that could give rise to the termination of the agreement related to the acquisition; significant transaction costs or unknown or inestimable liabilities; the risk of stockholder litigation in connection with the pending acquisition; risks related to future opportunities and plans for the combined company, including the uncertainty of expected future financial performance and results of the combined company after the acquisition closes; effects related to the announcement or completion of the acquisition on the market price of our common stock; and the possibility that, if we do not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of our common stock could decline - International Operations – worldwide and local economic and market conditions; changes in political conditions; and fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets
-
Our Business – changes in our markets due to competitive conditions, technological developments, environmental standards, laws and regulations, and customer preferences; fluctuations in demand affecting sales to customers; execution and integration of acquisitions, including the pending acquisition of
Vestcom ; selling prices; fluctuations in the cost and availability of raw materials and energy; the impact of competitive products and pricing; customer and supplier concentrations or consolidations; financial condition of distributors; outsourced manufacturers; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; successful implementation of new manufacturing technologies and installation of manufacturing equipment; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; and collection of receivables from customers - Income Taxes – fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; and the realization of deferred tax assets
- Information Technology – disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; and data security breaches
- Human Capital – recruitment and retention of employees; fluctuations in employee benefit costs; and collective labor arrangements
- Our Indebtedness – credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; volatility of financial markets; fluctuations in interest rates; and compliance with our debt covenants
- Ownership of Our Stock – potential significant variability of our stock price and amounts of future dividends and share repurchases
- Legal and Regulatory Matters – protection and infringement of intellectual property and impact of legal and regulatory proceedings, including with respect to environmental, health and safety, anti-corruption and trade compliance
- Other Financial Matters – fluctuations in pension costs and goodwill impairment
For a more detailed discussion of these factors, see “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2020 Form 10-K, filed with the
The forward-looking statements included in this document are made only as of the date of this document, and we undertake no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law.
For more information and to listen to a live broadcast or an audio replay of the quarterly conference call with analysts, visit the
Second Quarter Financial Summary - Preliminary, unaudited | ||||||||||||||||||||||||
(In millions, except % and per share amounts) | ||||||||||||||||||||||||
2Q | 2Q | % Sales Change vs. P/Y | ||||||||||||||||||||||
2021 |
2020 |
Reported | Ex. Currency | Organic | ||||||||||||||||||||
(a) | (b) | |||||||||||||||||||||||
Net sales, by segment: | ||||||||||||||||||||||||
Label and Graphic Materials |
|
|
24.9% |
16.8% |
16.1% |
|||||||||||||||||||
Retail Branding and Information Solutions |
529.3 |
294.9 |
79.5% |
72.5% |
72.2% |
|||||||||||||||||||
Industrial and Healthcare Materials |
196.5 |
132.1 |
48.8% |
39.3% |
32.9% |
|||||||||||||||||||
Total net sales |
|
|
37.5% |
29.2% |
28.1% |
|||||||||||||||||||
As Reported (GAAP) | Adjusted Non-GAAP (c) | |||||||||||||||||||||||
2Q | 2Q | % | % of Sales | 2Q | 2Q | % | % of Sales | |||||||||||||||||
2021 |
2020 |
Change |
2021 |
2020 |
2021 |
2020 |
Change |
2021 |
2020 |
|||||||||||||||
Operating income (loss) / operating margins before interest, other non-operating expense (income), and taxes, by segment: | ||||||||||||||||||||||||
Label and Graphic Materials |
|
|
16.6% |
12.5% |
|
|
14.5% |
14.8% |
||||||||||||||||
Retail Branding and Information Solutions |
42.1 |
(10.7) |
8.0% |
(3.6%) |
69.6 |
2.2 |
13.1% |
0.7% |
||||||||||||||||
Industrial and Healthcare Materials |
22.5 |
7.5 |
11.5% |
5.7% |
23.0 |
9.0 |
11.7% |
6.8% |
||||||||||||||||
Corporate expense |
(22.8) |
(10.8) |
(22.9) |
(11.0) |
||||||||||||||||||||
Total operating income / operating margins before interest, other non-operating expense (income), and taxes |
|
|
119% |
12.8% |
8.1% |
|
|
65% |
12.8% |
10.7% |
||||||||||||||
Interest expense |
|
|
|
|
||||||||||||||||||||
Other non-operating expense (income), net |
( |
|
( |
|
||||||||||||||||||||
Income before taxes |
|
|
147% |
12.1% |
6.8% |
|
|
78% |
12.1% |
9.4% |
||||||||||||||
Provision for (benefit from) income taxes |
|
|
|
|
||||||||||||||||||||
Equity method investment (losses) gains |
( |
( |
( |
( |
||||||||||||||||||||
Net income |
|
|
131% |
8.7% |
5.2% |
|
|
77% |
9.0% |
7.0% |
||||||||||||||
Net income per common share, assuming dilution |
|
|
131% |
|
|
77% |
||||||||||||||||||
2Q Free Cash Flow (d) |
|
|
||||||||||||||||||||||
YTD Free Cash Flow (d) |
|
|
See accompanying schedules A-4 to A-10 for reconciliations from GAAP to non-GAAP financial measures. | ||||||||||||||||||||||||
(a) | Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, the calendar shift resulting from the extra week in the prior fiscal year and currency adjustment for transitional reporting of highly inflationary economies. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. | |||||||||||||||||||||||
(b) | Organic sales change refers to sales change ex. currency, excluding the estimated impact of product line exits, acquisitions and divestitures. | |||||||||||||||||||||||
(c) | Excludes impact of restructuring charges and other items. Corporate expense excludes impact of severance and related costs of ( |
|||||||||||||||||||||||
(d) | Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. |
A-1 |
|||||||||||||||||||
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||||||
(In millions, except per share amounts) | |||||||||||||||||||
(UNAUDITED) | |||||||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||||||
|
|
|
|
||||||||||||||||
Net sales | $ |
2,102.0 |
|
$ |
1,528.5 |
|
$ |
4,153.3 |
|
$ |
3,251.5 |
|
|||||||
Cost of products sold |
1,525.7 |
|
1,145.6 |
|
2,980.0 |
|
2,383.5 |
|
|||||||||||
Gross profit |
576.3 |
|
382.9 |
|
1,173.3 |
|
868.0 |
|
|||||||||||
Marketing, general and administrative expense |
307.0 |
|
219.4 |
|
619.3 |
|
500.4 |
|
|||||||||||
Other expense (income), net(1) |
(0.6 |
) |
40.0 |
|
0.3 |
|
44.9 |
|
|||||||||||
Interest expense |
16.0 |
|
20.0 |
|
32.2 |
|
38.8 |
|
|||||||||||
Other non-operating expense (income), net(2) |
(1.4 |
) |
0.2 |
|
(2.7 |
) |
(0.3 |
) |
|||||||||||
Income before taxes |
255.3 |
|
103.3 |
|
524.2 |
|
284.2 |
|
|||||||||||
Provision for (benefit from) income taxes |
70.4 |
|
22.2 |
|
128.5 |
|
68.5 |
|
|||||||||||
Equity method investment (losses) gains |
(1.1 |
) |
(1.4 |
) |
(2.4 |
) |
(1.8 |
) |
|||||||||||
Net income | $ |
183.8 |
|
$ |
79.7 |
|
$ |
393.3 |
|
$ |
213.9 |
|
|||||||
Per share amounts: | |||||||||||||||||||
Net income per common share, assuming dilution | $ |
2.19 |
|
$ |
0.95 |
|
$ |
4.69 |
|
$ |
2.55 |
|
|||||||
Weighted average number of common shares outstanding, assuming dilution |
83.8 |
|
83.8 |
|
83.9 |
|
83.9 |
|
(1) |
"Other expense (income), net" for the second quarter of 2021 includes outcomes of legal proceedings, net, of |
||||||||||||||||||
|
"Other expense (income), net" for the second quarter of 2020 includes severance and related costs of |
||||||||||||||||||
|
"Other expense (income), net" for the first half of 2021 includes severance and related costs of |
||||||||||||||||||
|
"Other expense (income), net" for the first half of 2020 includes severance and related costs of |
||||||||||||||||||
(2) |
"Other non-operating expense (income), net" for the first half of 2021 includes pension plan settlement loss of |
A-2 |
|||||||||||||||
PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||||||
(In millions) | |||||||||||||||
(UNAUDITED) | |||||||||||||||
ASSETS | |||||||||||||||
Current assets: | |||||||||||||||
Cash and cash equivalents | $ |
344.8 |
$ |
262.6 |
|
||||||||||
Trade accounts receivable, net |
1,338.9 |
1,114.6 |
|
||||||||||||
Inventories, net |
824.8 |
726.6 |
|
||||||||||||
Other current assets |
233.1 |
220.8 |
|
||||||||||||
Total current assets |
2,741.6 |
2,324.6 |
|
||||||||||||
Property, plant and equipment, net |
1,344.8 |
1,228.8 |
|
||||||||||||
1,361.7 |
1,235.3 |
|
|||||||||||||
Deferred tax assets |
188.5 |
211.1 |
|
||||||||||||
Other assets |
785.9 |
651.9 |
|
||||||||||||
$ |
6,422.5 |
$ |
5,651.7 |
|
|||||||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||||
Current liabilities: | |||||||||||||||
Short-term borrowings and current portion of long-term debt and finance leases | $ |
33.6 |
$ |
268.6 |
|
||||||||||
Accounts payable |
1,226.5 |
956.5 |
|
||||||||||||
Other current liabilities |
822.4 |
684.4 |
|
||||||||||||
Total current liabilities |
2,082.5 |
1,909.5 |
|
||||||||||||
Long-term debt and finance leases |
2,020.2 |
1,997.6 |
|
||||||||||||
Other long-term liabilities |
616.2 |
530.7 |
|
||||||||||||
Shareholders' equity: | |||||||||||||||
Common stock |
124.1 |
124.1 |
|
||||||||||||
Capital in excess of par value |
846.5 |
840.0 |
|
||||||||||||
Retained earnings |
3,637.3 |
3,100.2 |
|
||||||||||||
(2,576.7 |
) |
(2,447.2 |
) |
||||||||||||
Accumulated other comprehensive loss |
(327.6 |
) |
(403.2 |
) |
|||||||||||
Total shareholders' equity |
1,703.6 |
1,213.9 |
|
||||||||||||
$ |
6,422.5 |
$ |
5,651.7 |
|
A-3 |
|||||||||
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||
(In millions) | |||||||||
(UNAUDITED) | |||||||||
Six Months Ended | |||||||||
Operating Activities: | |||||||||
Net income | $ |
393.3 |
|
$ |
213.9 |
|
|||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||
Depreciation |
80.8 |
|
74.6 |
|
|||||
Amortization |
28.8 |
|
23.2 |
|
|||||
Provision for credit losses and sales returns |
17.5 |
|
38.8 |
|
|||||
Stock-based compensation |
18.5 |
|
1.4 |
|
|||||
Pension plan settlement loss |
0.4 |
|
--- |
|
|||||
Deferred taxes and other non-cash taxes |
10.6 |
|
16.4 |
|
|||||
Other non-cash expense and loss (income and gain), net |
13.8 |
|
16.7 |
|
|||||
Changes in assets and liabilities and other adjustments |
(86.9 |
) |
(201.0 |
) |
|||||
Net cash provided by operating activities |
476.8 |
|
184.0 |
|
|||||
Investing Activities: | |||||||||
Purchases of property, plant and equipment |
(83.8 |
) |
(63.9 |
) |
|||||
Purchases of software and other deferred charges |
(6.4 |
) |
(11.0 |
) |
|||||
Proceeds from sales of property, plant and equipment |
1.0 |
|
0.1 |
|
|||||
Proceeds from insurance and sales (purchases) of investments, net |
0.4 |
|
(0.4 |
) |
|||||
Proceeds from sale of product line |
6.7 |
|
--- |
|
|||||
Payments for acquisitions, net of cash acquired, and investments in businesses |
(33.8 |
) |
(252.8 |
) |
|||||
Net cash used in investing activities |
(115.9 |
) |
(328.0 |
) |
|||||
Financing Activities: | |||||||||
Net increase (decrease) in borrowings with maturities of three months or less |
(36.2 |
) |
92.5 |
|
|||||
Additional borrowings under revolving credit facility |
--- |
|
500.0 |
|
|||||
Repayments of revolving credit facility |
--- |
|
(500.0 |
) |
|||||
Additional long-term borrowings |
--- |
|
493.7 |
|
|||||
Repayments of long-term debt and finance leases |
(3.1 |
) |
(267.6 |
) |
|||||
Dividends paid |
(108.0 |
) |
(96.8 |
) |
|||||
Share repurchases |
(95.0 |
) |
(45.2 |
) |
|||||
Net (tax withholding) proceeds related to stock-based compensation |
(25.3 |
) |
(20.5 |
) |
|||||
Net cash (used in) provided by financing activities |
(267.6 |
) |
156.1 |
|
|||||
Effect of foreign currency translation on cash balances |
(0.8 |
) |
(3.2 |
) |
|||||
Increase (decrease) in cash and cash equivalents |
92.5 |
|
8.9 |
|
|||||
Cash and cash equivalents, beginning of year |
252.3 |
|
253.7 |
|
|||||
Cash and cash equivalents, end of period | $ |
344.8 |
|
$ |
262.6 |
|
A-4
Reconciliation of Non-GAAP Financial Measures to GAAP
We report our financial results in conformity with accounting principles generally accepted in
Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, outcomes of certain legal proceedings, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on investments, and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.
We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period and full year, as applicable.
We use the non-GAAP financial measures described below in the accompanying news release and presentation.
Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, the calendar shift resulting from the extra week in the prior fiscal year and currency adjustment for transitional reporting of highly inflationary economies. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations.
Organic sales change refers to sales change ex. currency, excluding the estimated impact of product line exits, acquisitions and divestitures.
We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period.
Adjusted operating income refers to income before taxes; interest expense; other non-operating expense (income), net; and other expense (income), net.
Adjusted EBITDA refers to adjusted operating income before depreciation and amortization.
Adjusted operating margin refers to adjusted operating income as a percentage of net sales.
Adjusted EBITDA margin refers to adjusted EBITDA as a percentage of net sales.
Adjusted tax rate refers to the projected full-year GAAP tax rate, adjusted to exclude certain unusual or infrequent events that are expected to significantly impact that rate, such as effects of certain discrete tax planning actions, impacts related to the enactment of the
Adjusted net income refers to income before taxes, tax-effected at the adjusted tax rate, and adjusted for tax-effected restructuring charges and other items.
Adjusted net income per common share, assuming dilution (adjusted EPS) refers to adjusted net income divided by weighted average number of common shares outstanding, assuming dilution.
We believe that adjusted operating margin, adjusted EBITDA margin, adjusted net income, and adjusted EPS assist investors in understanding our core operating trends and comparing our results with those of our competitors.
Net debt to adjusted EBITDA ratio refers to total debt (including finance leases) less cash and cash equivalents, divided by adjusted EBITDA for the last twelve months. We believe that the net debt to adjusted EBITDA ratio assists investors in assessing our leverage position.
Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. We believe that free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases, and acquisitions.
Reconciliations are provided in accordance with Regulations G and S-K and reconcile our non-GAAP financial measures with the most directly comparable GAAP financial measures.
A-5 |
||||||||||||||||
PRELIMINARY RECONCILIATION FROM GAAP TO NON-GAAP FINANCIAL MEASURES | ||||||||||||||||
(In millions, except % and per share amounts) | ||||||||||||||||
(UNAUDITED) | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
Reconciliation from GAAP to Non-GAAP operating margins: | ||||||||||||||||
Net sales | $ |
2,102.0 |
|
$ |
1,528.5 |
|
$ |
4,153.3 |
|
$ |
3,251.5 |
|
||||
Income before taxes | $ |
255.3 |
|
$ |
103.3 |
|
$ |
524.2 |
|
$ |
284.2 |
|
||||
Income before taxes as a percentage of net sales |
12.1% |
6.8% |
12.6% |
8.7% |
||||||||||||
Adjustments: | ||||||||||||||||
Interest expense | $ |
16.0 |
|
$ |
20.0 |
|
$ |
32.2 |
|
$ |
38.8 |
|
||||
Other non-operating expense (income), net |
(1.4 |
) |
0.2 |
|
(2.7 |
) |
(0.3 |
) |
||||||||
Operating income before interest expense, other non-operating expense (income), and taxes | $ |
269.9 |
|
$ |
123.5 |
|
$ |
553.7 |
|
$ |
322.7 |
|
||||
Operating margins |
12.8% |
8.1% |
13.3% |
9.9% |
||||||||||||
Income before taxes | $ |
255.3 |
|
$ |
103.3 |
|
$ |
524.2 |
|
$ |
284.2 |
|
||||
Adjustments: | ||||||||||||||||
Restructuring charges: | ||||||||||||||||
Severance and related costs |
1.6 |
|
37.5 |
|
4.0 |
|
39.9 |
|
||||||||
Asset impairment and lease cancellation charges |
0.1 |
|
1.8 |
|
0.6 |
|
1.8 |
|
||||||||
Loss on sale of assets, net |
0.2 |
|
--- |
|
0.2 |
|
--- |
|
||||||||
Transaction and related costs |
--- |
|
0.7 |
|
0.7 |
|
3.2 |
|
||||||||
Gain on sale of product line |
--- |
|
--- |
|
(4.8 |
) |
--- |
|
||||||||
Outcomes of legal proceedings, net(1) |
(2.5 |
) |
--- |
|
(0.4 |
) |
--- |
|
||||||||
Interest expense |
16.0 |
|
20.0 |
|
32.2 |
|
38.8 |
|
||||||||
Other non-operating expense (income), net |
(1.4 |
) |
0.2 |
|
(2.7 |
) |
(0.3 |
) |
||||||||
Adjusted operating income (non-GAAP) | $ |
269.3 |
|
$ |
163.5 |
|
$ |
554.0 |
|
$ |
367.6 |
|
||||
Adjusted operating margins (non-GAAP) |
12.8% |
10.7% |
13.3% |
11.3% |
||||||||||||
Reconciliation from GAAP to Non-GAAP net income: | ||||||||||||||||
As reported net income | $ |
183.8 |
|
$ |
79.7 |
|
$ |
393.3 |
|
$ |
213.9 |
|
||||
Adjustments: | ||||||||||||||||
Restructuring charges and other items(2) |
(0.6 |
) |
40.0 |
|
0.3 |
|
44.9 |
|
||||||||
Pension plan settlement loss |
--- |
|
--- |
|
0.4 |
|
--- |
|
||||||||
Tax effect on restructuring charges and other items and impact of adjusted tax rate |
5.2 |
|
(13.2 |
) |
(4.3 |
) |
(12.8 |
) |
||||||||
Adjusted net income (non-GAAP) | $ |
188.4 |
|
$ |
106.5 |
|
$ |
389.7 |
|
$ |
246.0 |
|
(1) |
Second quarter of 2021 includes |
||||||||||||
The first half of 2021 includes |
|||||||||||||
(2) |
Includes pretax restructuring and related charges, loss on sale of assets, transaction and related costs, outcomes of legal proceedings, and gain on sale of product line. |
A-5 |
|||||||||||||||||
(continued) |
|||||||||||||||||
PRELIMINARY RECONCILIATION FROM GAAP TO NON-GAAP FINANCIAL MEASURES | |||||||||||||||||
(In millions, except % and per share amounts) | |||||||||||||||||
(UNAUDITED) | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
Reconciliation from GAAP to Non-GAAP net income per common share: | |||||||||||||||||
As reported net income per common share, assuming dilution | $ |
2.19 |
|
$ |
0.95 |
|
$ |
4.69 |
|
$ |
2.55 |
|
|||||
Adjustments per common share, net of tax: | |||||||||||||||||
Restructuring charges and other items(1) |
(0.01 |
) |
0.48 |
|
--- |
|
0.53 |
|
|||||||||
Tax effect on restructuring charges and other items and impact of adjusted tax rate |
0.07 |
|
(0.16 |
) |
(0.05 |
) |
(0.15 |
) |
|||||||||
Adjusted net income per common share, assuming dilution (non-GAAP) | $ |
2.25 |
|
$ |
1.27 |
|
$ |
4.64 |
|
$ |
2.93 |
|
|||||
Weighted average number of common shares outstanding, assuming dilution |
83.8 |
|
83.8 |
|
83.9 |
|
83.9 |
|
|||||||||
Our adjusted tax rate was 25.6% and 25.3% for the three and six months ended |
|||||||||||||||||
(1) Includes pretax restructuring and related charges, loss on sale of assets, transaction and related costs, outcomes of legal proceedings, and gain on sale of product line. | |||||||||||||||||
(UNAUDITED) | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
Reconciliation of free cash flow: | |||||||||||||||||
Net cash provided by operating activities | $ |
267.5 |
|
$ |
179.6 |
|
$ |
476.8 |
|
$ |
184.0 |
|
|||||
Purchases of property, plant and equipment |
(58.6 |
) |
(30.7 |
) |
(83.8 |
) |
(63.9 |
) |
|||||||||
Purchases of software and other deferred charges |
(4.1 |
) |
(4.8 |
) |
(6.4 |
) |
(11.0 |
) |
|||||||||
Proceeds from sales of property, plant and equipment |
0.3 |
|
0.1 |
|
1.0 |
|
0.1 |
|
|||||||||
Proceeds from insurance and sales (purchases) of investments, net |
0.9 |
|
(0.1 |
) |
0.4 |
|
(0.4 |
) |
|||||||||
Free cash flow (non-GAAP) | $ |
206.0 |
|
$ |
144.1 |
|
$ |
388.0 |
|
$ |
108.8 |
|
A-6 |
||||||||||||||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||||||||||||||||||
(In millions, except %) | ||||||||||||||||||||
(UNAUDITED) | ||||||||||||||||||||
Second Quarter Ended | ||||||||||||||||||||
OPERATING INCOME (LOSS) | OPERATING MARGINS | |||||||||||||||||||
2021 |
2020 |
2021 |
2020 |
2021 |
2020 |
|||||||||||||||
Label and Graphic Materials |
$ |
1,376.2 |
$ |
1,101.5 |
$ |
228.1 |
|
$ |
137.5 |
|
16.6 |
% |
12.5 |
% |
||||||
Retail Branding and Information Solutions |
|
529.3 |
|
294.9 |
|
42.1 |
|
|
(10.7 |
) |
8.0 |
% |
(3.6 |
%) |
||||||
Industrial and Healthcare Materials |
|
196.5 |
|
132.1 |
|
22.5 |
|
|
7.5 |
|
11.5 |
% |
5.7 |
% |
||||||
Corporate Expense |
|
N/A |
|
N/A |
|
(22.8 |
) |
|
(10.8 |
) |
N/A |
|
N/A |
|
||||||
TOTAL FROM OPERATIONS |
$ |
2,102.0 |
$ |
1,528.5 |
$ |
269.9 |
|
$ |
123.5 |
|
12.8 |
% |
8.1 |
% |
||||||
RECONCILIATION FROM GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION | ||||||||||||||||||||
Second Quarter Ended | ||||||||||||||||||||
OPERATING INCOME (LOSS) | OPERATING MARGINS | |||||||||||||||||||
|
2021 |
|
|
2020 |
|
2021 |
2020 |
|||||||||||||
Label and Graphic Materials | ||||||||||||||||||||
Operating income and margins, as reported |
$ |
228.1 |
|
$ |
137.5 |
|
16.6 |
% |
12.5 |
% |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: | ||||||||||||||||||||
Severance and related costs |
|
(0.1 |
) |
|
24.9 |
|
--- |
2.2 |
% |
|||||||||||
Asset impairment charges |
|
--- |
|
|
0.9 |
|
--- |
0.1 |
% |
|||||||||||
Outcome of legal proceeding(1) |
|
(28.4 |
) |
|
--- |
|
(2.1 |
%) |
--- |
|
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
199.6 |
|
$ |
163.3 |
|
14.5 |
% |
14.8 |
% |
||||||||||
Depreciation and amortization |
|
28.7 |
|
|
26.3 |
|
2.1 |
% |
2.4 |
% |
||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
228.3 |
|
$ |
189.6 |
|
16.6 |
% |
17.2 |
% |
||||||||||
Retail Branding and Information Solutions | ||||||||||||||||||||
Operating income (loss) and margins, as reported |
$ |
42.1 |
|
$ |
(10.7 |
) |
8.0 |
% |
(3.6 |
%) |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: | ||||||||||||||||||||
Severance and related costs |
|
1.3 |
|
|
11.3 |
|
0.2 |
% |
3.8 |
% |
||||||||||
Asset impairment charges |
|
0.1 |
|
|
0.9 |
|
--- |
|
0.3 |
% |
||||||||||
Loss on sale of asset |
|
0.2 |
|
|
--- |
|
--- |
|
--- |
|
||||||||||
Transaction and related costs |
|
--- |
|
|
0.7 |
|
--- |
|
0.2 |
% |
||||||||||
Outcomes of legal proceedings, net(2) |
|
25.9 |
|
|
--- |
|
4.9 |
% |
--- |
|
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
69.6 |
|
$ |
2.2 |
|
13.1 |
% |
0.7 |
% |
||||||||||
Depreciation and amortization |
|
19.4 |
|
|
17.7 |
|
3.7 |
% |
6.0 |
% |
||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
89.0 |
|
$ |
19.9 |
|
16.8 |
% |
6.7 |
% |
||||||||||
Industrial and Healthcare Materials | ||||||||||||||||||||
Operating income and margins, as reported |
$ |
22.5 |
|
$ |
7.5 |
|
11.5 |
% |
5.7 |
% |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: | ||||||||||||||||||||
Severance and related costs |
|
0.5 |
|
|
1.5 |
|
0.2 |
% |
1.1 |
% |
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
23.0 |
|
$ |
9.0 |
|
11.7 |
% |
6.8 |
% |
||||||||||
Depreciation and amortization |
|
7.1 |
|
|
6.3 |
|
3.6 |
% |
4.8 |
% |
||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
30.1 |
|
$ |
15.3 |
|
15.3 |
% |
11.6 |
% |
(1) |
Second quarter of 2021 includes |
||||||||||
(2) |
Second quarter of 2021 includes contingent liability related to patent infringement jury verdict of |
A-7 |
||||||||||||||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||||||||||||||||||
(In millions, except %) | ||||||||||||||||||||
(UNAUDITED) | ||||||||||||||||||||
Six Months Ended | ||||||||||||||||||||
OPERATING INCOME (LOSS) | OPERATING MARGINS | |||||||||||||||||||
2021 |
2020 |
2021 |
2020 |
2021 |
2020 |
|||||||||||||||
Label and Graphic Materials |
$ |
2,753.2 |
$ |
2,275.0 |
$ |
454.3 |
|
$ |
310.0 |
|
16.5 |
% |
13.6 |
% |
||||||
Retail Branding and Information Solutions |
|
1,012.0 |
|
696.8 |
|
102.1 |
|
|
20.2 |
|
10.1 |
% |
2.9 |
% |
||||||
Industrial and Healthcare Materials |
|
388.1 |
|
279.7 |
|
46.0 |
|
|
22.4 |
|
11.9 |
% |
8.0 |
% |
||||||
Corporate Expense |
|
N/A |
|
N/A |
|
(48.7 |
) |
|
(29.9 |
) |
N/A |
|
N/A |
|
||||||
TOTAL FROM OPERATIONS |
$ |
4,153.3 |
$ |
3,251.5 |
$ |
553.7 |
|
$ |
322.7 |
|
13.3 |
% |
9.9 |
% |
||||||
RECONCILIATION FROM GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION | ||||||||||||||||||||
Six Months Ended | ||||||||||||||||||||
OPERATING INCOME | OPERATING MARGINS | |||||||||||||||||||
|
2021 |
|
|
2020 |
|
2021 |
|
2020 |
|
|||||||||||
Label and Graphic Materials | ||||||||||||||||||||
Operating income and margins, as reported |
$ |
454.3 |
|
$ |
310.0 |
|
16.5 |
% |
13.6 |
% |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: | ||||||||||||||||||||
Severance and related costs |
|
0.5 |
|
|
25.3 |
|
--- |
|
1.1 |
% |
||||||||||
Asset impairment charges |
|
0.1 |
|
|
0.9 |
|
--- |
|
0.1 |
% |
||||||||||
Transaction and related costs |
|
0.1 |
|
|
0.7 |
|
--- |
|
--- |
|
||||||||||
Outcomes of legal proceedings, net(1) |
|
(26.3 |
) |
|
--- |
|
(0.9 |
%) |
--- |
|
||||||||||
Gain on sale of product line |
|
(4.8 |
) |
|
--- |
|
(0.2 |
%) |
--- |
|
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
423.9 |
|
$ |
336.9 |
|
15.4 |
% |
14.8 |
% |
||||||||||
Depreciation and amortization |
|
57.7 |
|
|
52.4 |
|
2.1 |
% |
2.3 |
% |
||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
481.6 |
|
$ |
389.3 |
|
17.5 |
% |
17.1 |
% |
||||||||||
Retail Branding and Information Solutions | ||||||||||||||||||||
Operating income and margins, as reported |
$ |
102.1 |
|
$ |
20.2 |
|
10.1 |
% |
2.9 |
% |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: | ||||||||||||||||||||
Severance and related costs |
|
2.5 |
|
|
12.8 |
|
0.2 |
% |
1.8 |
% |
||||||||||
Asset impairment and lease cancellation charges |
|
0.5 |
|
|
0.9 |
|
0.1 |
% |
0.1 |
% |
||||||||||
Transaction and related costs |
|
0.2 |
|
|
2.5 |
|
--- |
|
0.4 |
% |
||||||||||
Loss on sale of asset |
|
0.5 |
|
|
--- |
|
--- |
|
--- |
|
||||||||||
Outcomes of legal proceedings, net(2) |
|
25.9 |
|
|
--- |
|
2.6 |
% |
--- |
|
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
131.7 |
|
$ |
36.4 |
|
13.0 |
% |
5.2 |
% |
||||||||||
Depreciation and amortization |
|
38.0 |
|
|
32.6 |
|
3.8 |
% |
4.7 |
% |
||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
169.7 |
|
$ |
69.0 |
|
16.8 |
% |
9.9 |
% |
||||||||||
Industrial and Healthcare Materials | ||||||||||||||||||||
Operating income and margins, as reported |
$ |
46.0 |
|
$ |
22.4 |
|
11.9 |
% |
8.0 |
% |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: | ||||||||||||||||||||
Severance and related costs |
|
0.5 |
|
|
2.0 |
|
0.1 |
% |
0.7 |
% |
||||||||||
Transaction and related costs |
|
0.4 |
|
|
--- |
|
0.1 |
% |
--- |
|
||||||||||
Gain on sale of assets |
|
(0.3 |
) |
|
--- |
|
(0.1 |
%) |
--- |
|
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
46.6 |
|
$ |
24.4 |
|
12.0 |
% |
8.7 |
% |
||||||||||
Depreciation and amortization |
|
13.9 |
|
|
12.8 |
|
3.6 |
% |
4.6 |
% |
||||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
60.5 |
|
$ |
37.2 |
|
15.6 |
% |
13.3 |
% |
(1) |
The first half of 2021 includes |
||||||||||
(2) |
The first half of 2021 includes contingent liability related to patent infringement jury verdict of $26.6, partially offset by |
A-8 |
||||||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||||||||||
Reconciliation of Adjusted EBITDA Margins | ||||||||||||
(In millions, except %) | ||||||||||||
(UNAUDITED) | ||||||||||||
(13 weeks) | (13 weeks) | (13 weeks) | ||||||||||
Label and Graphic Materials |
2Q21 |
2Q20 |
2Q19 |
|||||||||
Net sales |
$ |
1,376.2 |
|
$ |
1,101.5 |
|
$ |
1,206.3 |
|
|||
Operating income before interest expense, | ||||||||||||
other non-operating expense (income) and taxes, as reported |
$ |
228.1 |
|
$ |
137.5 |
|
$ |
162.1 |
|
|||
Operating margins, as reported |
|
16.6 |
% |
|
12.5 |
% |
|
13.4 |
% |
|||
Non-GAAP adjustments: | ||||||||||||
Restructuring charges: | ||||||||||||
Severance and related costs |
$ |
(0.1 |
) |
$ |
24.9 |
|
$ |
3.4 |
|
|||
Asset impairment charges |
|
- |
|
|
0.9 |
|
|
1.0 |
|
|||
Other items |
|
(28.4 |
) |
|
- |
|
|
- |
|
|||
Adjusted operating income (non-GAAP) |
$ |
199.6 |
|
$ |
163.3 |
|
$ |
166.5 |
|
|||
Adjusted operating margins (non-GAAP) |
|
14.5 |
% |
|
14.8 |
% |
|
13.8 |
% |
|||
Depreciation and amortization |
$ |
28.7 |
|
$ |
26.3 |
|
$ |
25.0 |
|
|||
Adjusted EBITDA (non-GAAP) |
$ |
228.3 |
|
$ |
189.6 |
|
$ |
191.5 |
|
|||
Adjusted EBITDA margins (non-GAAP) |
|
16.6 |
% |
|
17.2 |
% |
|
15.9 |
% |
|||
Retail Branding and Information Solutions |
2Q21 |
2Q20 |
2Q19 |
|||||||||
Net sales |
$ |
529.3 |
|
$ |
294.9 |
|
$ |
418.3 |
|
|||
Operating income (loss) before interest expense, | ||||||||||||
other non-operating expense (income) and taxes, as reported |
$ |
42.1 |
|
$ |
(10.7 |
) |
$ |
50.4 |
|
|||
Operating margins, as reported |
|
8.0 |
% |
|
(3.6 |
%) |
|
12.0 |
% |
|||
Non-GAAP adjustments: | ||||||||||||
Restructuring charges: | ||||||||||||
Severance and related costs |
$ |
1.3 |
|
$ |
11.3 |
|
$ |
1.3 |
|
|||
Asset impairment charges |
|
0.1 |
|
|
0.9 |
|
|
0.4 |
|
|||
Other items |
|
26.1 |
|
|
0.7 |
|
|
- |
|
|||
Adjusted operating income (non-GAAP) |
$ |
69.6 |
|
$ |
2.2 |
|
$ |
52.1 |
|
|||
Adjusted operating margins (non-GAAP) |
|
13.1 |
% |
|
0.7 |
% |
|
12.5 |
% |
|||
Depreciation and amortization |
$ |
19.4 |
|
$ |
17.7 |
|
$ |
13.2 |
|
|||
Adjusted EBITDA (non-GAAP) |
$ |
89.0 |
|
$ |
19.9 |
|
$ |
65.3 |
|
|||
Adjusted EBITDA margins (non-GAAP) |
|
16.8 |
% |
|
6.7 |
% |
|
15.6 |
% |
|||
Industrial and Healthcare Materials |
2Q21 |
2Q20 |
2Q19 |
|||||||||
Net sales |
$ |
196.5 |
|
$ |
132.1 |
|
$ |
171.1 |
|
|||
Operating income before interest expense, | ||||||||||||
other non-operating expense (income) and taxes, as reported |
$ |
22.5 |
|
$ |
7.5 |
|
$ |
16.5 |
|
|||
Operating margins, as reported |
|
11.5 |
% |
|
5.7 |
% |
|
9.6 |
% |
|||
Non-GAAP adjustments: | ||||||||||||
Restructuring charges: | ||||||||||||
Severance and related costs |
$ |
0.5 |
|
$ |
1.5 |
|
$ |
1.4 |
|
|||
Adjusted operating income (non-GAAP) |
$ |
23.0 |
|
$ |
9.0 |
|
$ |
17.9 |
|
|||
Adjusted operating margins (non-GAAP) |
|
11.7 |
% |
|
6.8 |
% |
|
10.5 |
% |
|||
Depreciation and amortization |
$ |
7.1 |
|
$ |
6.3 |
|
$ |
6.7 |
|
|||
Adjusted EBITDA (non-GAAP) |
$ |
30.1 |
|
$ |
15.3 |
|
$ |
24.6 |
|
|||
Adjusted EBITDA margins (non-GAAP) |
|
15.3 |
% |
|
11.6 |
% |
|
14.4 |
% |
|||
Corporate expense |
2Q21 |
2Q20 |
2Q19 |
|||||||||
Corporate expense, as reported |
$ |
(22.8 |
) |
$ |
(10.8 |
) |
$ |
(19.9 |
) |
|||
Non-GAAP adjustments: | ||||||||||||
Restructuring charges: | ||||||||||||
Severance and related costs |
|
(0.1 |
) |
|
(0.2 |
) |
|
- |
|
|||
Corporate expense (non-GAAP) |
$ |
(22.9 |
) |
$ |
(11.0 |
) |
$ |
(19.9 |
) |
|||
Total Company |
2Q21 |
2Q20 |
2Q19 |
|||||||||
Net sales |
$ |
2,102.0 |
|
$ |
1,528.5 |
|
$ |
1,795.7 |
|
|||
Operating income before interest expense, | ||||||||||||
other non-operating expense (income) and taxes, as reported |
$ |
269.9 |
|
$ |
123.5 |
|
$ |
209.1 |
|
|||
Operating margins, as reported |
|
12.8 |
% |
|
8.1 |
% |
|
11.6 |
% |
|||
Non-GAAP adjustments: | ||||||||||||
Restructuring charges: | ||||||||||||
Severance and related costs |
$ |
1.6 |
|
$ |
37.5 |
|
$ |
6.1 |
|
|||
Asset impairment and lease cancellation charges |
|
0.1 |
|
|
1.8 |
|
|
1.4 |
|
|||
Other items |
|
(2.3 |
) |
|
0.7 |
|
|
- |
|
|||
Adjusted operating income (non-GAAP) |
$ |
269.3 |
|
$ |
163.5 |
|
$ |
216.6 |
|
|||
Adjusted operating margins (non-GAAP) |
|
12.8 |
% |
|
10.7 |
% |
|
12.1 |
% |
|||
Depreciation and amortization |
$ |
55.2 |
|
$ |
50.3 |
|
$ |
44.9 |
|
|||
Adjusted EBITDA (non-GAAP) |
$ |
324.5 |
|
$ |
213.8 |
|
$ |
261.5 |
|
|||
Adjusted EBITDA margins (non-GAAP) |
|
15.4 |
% |
|
14.0 |
% |
|
14.6 |
% |
A-9 |
||||||||||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||||||||||||||
Reconciliation of Adjusted EBITDA Margins and Net Debt to Adjusted EBITDA | ||||||||||||||||
(In millions, except %) | ||||||||||||||||
(UNAUDITED) | ||||||||||||||||
(13 weeks) | (14 weeks) | (13 weeks) | (13 weeks) | |||||||||||||
QTD | ||||||||||||||||
Total Company |
3Q20 |
4Q20 |
1Q21 |
2Q21 |
||||||||||||
Net sales |
$ |
1,729.1 |
|
$ |
1,990.9 |
|
$ |
2,051.3 |
|
$ |
2,102.0 |
|
||||
Operating income before interest expense, | ||||||||||||||||
other non-operating expense (income) and taxes, as reported |
$ |
213.5 |
|
$ |
273.0 |
|
$ |
283.8 |
|
$ |
269.9 |
|
||||
Operating margins, as reported |
|
12.3 |
% |
|
13.7 |
% |
|
13.8 |
% |
|
12.8 |
% |
||||
Non-GAAP adjustments: | ||||||||||||||||
Restructuring charges: | ||||||||||||||||
Severance and related costs |
$ |
6.5 |
|
$ |
2.7 |
|
$ |
2.4 |
|
$ |
1.6 |
|
||||
Asset impairment and lease cancellation charges |
|
4.4 |
|
|
- |
|
|
0.5 |
|
|
0.1 |
|
||||
Other items |
|
1.5 |
|
|
(6.4 |
) |
|
(2.0 |
) |
|
(2.3 |
) |
||||
Adjusted operating income (non-GAAP) |
$ |
225.9 |
|
$ |
269.3 |
|
$ |
284.7 |
|
$ |
269.3 |
|
||||
Adjusted operating margins (non-GAAP) |
|
13.1 |
% |
|
13.5 |
% |
|
13.9 |
% |
|
12.8 |
% |
||||
Depreciation and amortization |
$ |
52.0 |
|
$ |
55.5 |
|
$ |
54.4 |
|
$ |
55.2 |
|
||||
Adjusted EBITDA (non-GAAP) |
$ |
277.9 |
|
$ |
324.8 |
|
$ |
339.1 |
|
$ |
324.5 |
|
||||
Adjusted EBITDA margins (non-GAAP) |
|
16.1 |
% |
|
16.3 |
% |
|
16.5 |
% |
|
15.4 |
% |
||||
Total Debt |
$ |
2,053.8 |
|
|||||||||||||
Less: Cash and cash equivalents |
|
344.8 |
|
|||||||||||||
Net Debt |
$ |
1,709.0 |
|
|||||||||||||
Net Debt to Adjusted EBITDA LTM* (non-GAAP) |
|
1.3 |
|
|||||||||||||
*LTM = Last twelve months (3Q20 to 2Q21) |
A-10 |
||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||||||
(UNAUDITED) | ||||||||
Second Quarter 2021 (vs. 2020) | ||||||||
Total Company |
Label and Graphic Materials |
Retail Branding and Information Solutions |
Industrial and Healthcare Materials |
|||||
Reconciliation from GAAP to Non-GAAP sales change | ||||||||
Reported net sales change |
37.5% |
24.9% |
79.5% |
48.8% |
||||
Foreign currency translation |
(8.3%) |
(8.2%) |
(6.9%) |
(9.4%) |
||||
Extra week impact |
--- |
--- |
--- |
--- |
||||
Sales change ex. currency (non-GAAP)(1) |
29.2% |
16.8% |
72.5% |
39.3% |
||||
Acquisitions and product line exit |
(1.1%) |
(0.7%) |
(0.3%) |
(6.4%) |
||||
Organic sales change (non-GAAP)(1) |
28.1% |
16.1% |
72.2% |
32.9% |
||||
Second Quarter 2021 (vs. 2019)(2) | ||||||||
Total Company |
Label and Graphic Materials |
Retail Branding and Information Solutions |
Industrial and Healthcare Materials |
|||||
Reconciliation from GAAP to Non-GAAP sales change | ||||||||
Reported net sales change |
17.1% |
14.1% |
26.5% |
14.8% |
||||
Foreign currency translation |
(2.8%) |
(3.1%) |
(1.3%) |
(4.1%) |
||||
Extra week impact |
--- |
--- |
--- |
--- |
||||
Sales change ex. currency (non-GAAP)(1) |
14.3% |
11.0% |
25.2% |
10.7% |
||||
Acquisitions and product line exit |
(3.3%) |
(0.3%) |
(11.1%) |
(5.1%) |
||||
Organic sales change (non-GAAP)(1) |
11.0% |
10.7% |
14.1% |
5.6% |
||||
Six Months Ended 2021 (vs. 2020) | ||||||||
Total Company |
Label and Graphic Materials |
Retail Branding and Information Solutions |
Industrial and Healthcare Materials |
|||||
Reconciliation from GAAP to Non-GAAP sales change | ||||||||
Reported net sales change |
27.7% |
21.0% |
45.2% |
38.8% |
||||
Foreign currency translation |
(6.1%) |
(6.5%) |
(3.7%) |
(7.8%) |
||||
Extra week impact |
(2.2%) |
(2.1%) |
(2.4%) |
(2.5%) |
||||
Sales change ex. currency (non-GAAP)(1) |
19.4% |
12.4% |
39.2% |
28.4% |
||||
Acquisitions and product line exit |
(1.6%) |
(0.8%) |
(3.4%) |
(4.4%) |
||||
Organic sales change (non-GAAP)(1) |
17.8% |
11.7% |
35.8% |
24.1% |
(1) |
Totals may not sum due to rounding. |
|||||
(2) |
Second quarter 2021 vs. 2019 results are presented to facilitate comparison with pre-pandemic performance. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210728005356/en/
Media Relations:
rob.six@averydennison.com
Investor Relations:
john.eble@averydennison.com
Source: